Universal Health stock forecast
Universal Health (UHS) Stock Forecast & Price Target
UHS Analyst Ratings
UHS Stock 12 Month Forecast
Average Price Target
CHF165.83▲(0.00% Upside)Detailed List of Analyst Forecasts​
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Ann Hynes | Mizuho Securities | CHF189.72 | buy | ― | Reiterated | 11/15/26 | ||
| Sarah James | Cantor Fitzgerald | ― | hold | ― | Reiterated | 11/11/26 | ||
| Ben Hendrix | RBC Capital | CHF154.30→CHF174.54 | hold | ― | Reiterated | 11/10/26 | ||
| Scott Fidel | Goldman Sachs | CHF160.21 | hold | ― | Reiterated | 11/09/26 | ||
| Kevin Fischbeck | Bank of America Securities | ― | sell | ― | Reiterated | 11/05/26 | ||
| Stephen Baxter | Wells Fargo | CHF139.97→CHF143.34 | hold | ― | Assigned | 11/02/26 | ||
| A.J. Rice | UBS | CHF244.53→CHF210.80 | buy | ― | Reiterated | 10/30/26 | ||
| Craig Hettenbach | Morgan Stanley | CHF161.05 | hold | ― | Assigned | 10/29/26 | ||
| Matthew Gillmor CFA | KeyBanc | ― | hold | ― | Reiterated | 10/29/26 | ||
| Michael Ha | Robert W. Baird | CHF139.97→CHF131.54 | hold | ― | Reiterated | 10/29/26 | ||
| Ryan Langston | TD Cowen | CHF166.11 | buy | ― | Reiterated | 10/29/26 | ||
| Andrew Mok CFA | Barclays | CHF141.66 | hold | ― | Reiterated | 10/28/26 | ||
| Jason Cassorla | Guggenheim | CHF176.23→CHF169.48 | buy | ― | Reiterated | 10/28/26 | ||
| John Ransom | Raymond James | ― | hold | ― | Reiterated | 09/28/26 | ||
| Whit Mayo | Leerink Partners | CHF166.95→CHF172.86 | buy | ― | Reiterated | 09/18/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Ann HynesMizuho Securities | BuyReiteratedCHF189.72 | 11/15/26 | ― | ||
| Sarah JamesCantor Fitzgerald | HoldReiterated | 11/11/26 | ― | ||
| Ben HendrixRBC Capital | HoldReiteratedCHF154.30→CHF174.54 | 11/10/26 | ― | ||
| Scott FidelGoldman Sachs | HoldReiteratedCHF160.21 | 11/09/26 | ― | ||
| Kevin FischbeckBank of America Securities | SellReiterated | 11/05/26 | ― | ||
| Stephen BaxterWells Fargo | HoldAssignedCHF139.97→CHF143.34 | 11/02/26 | ― | ||
| A.J. RiceUBS | BuyReiteratedCHF244.53→CHF210.80 | 10/30/26 | ― | ||
| Craig HettenbachMorgan Stanley | HoldAssignedCHF161.05 | 10/29/26 | ― | ||
| Matthew Gillmor CFAKeyBanc | HoldReiterated | 10/29/26 | ― | ||
| Michael HaRobert W. Baird | HoldReiteratedCHF139.97→CHF131.54 | 10/29/26 | ― | ||
| Ryan LangstonTD Cowen | BuyReiteratedCHF166.11 | 10/29/26 | ― | ||
| Andrew Mok CFABarclays | HoldReiteratedCHF141.66 | 10/28/26 | ― | ||
| Jason CassorlaGuggenheim | BuyReiteratedCHF176.23→CHF169.48 | 10/28/26 | ― | ||
| John RansomRaymond James | HoldReiterated | 09/28/26 | ― | ||
| Whit MayoLeerink Partners | BuyReiteratedCHF166.95→CHF172.86 | 09/18/26 | ― |
Best Analysts Covering Universal Health
Copying Whit Mayo's trades and holding each position for 3 Months would result in 68.75% of your transactions generating a profit, with an average return of +4.54% per trade.
Copying Ann Hynes's trades and holding each position for 1 Year would result in 73.08% of your transactions generating a profit, with an average return of +12.62% per trade.
Copying Jason Cassorla's trades and holding each position for 2 Years would result in 81.25% of your transactions generating a profit, with an average return of +22.12% per trade.
UHS Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 2 | 0 |
| Buy | 5 | 5 | 5 | 4 | 6 |
| Hold | 13 | 12 | 15 | 13 | 14 |
| Sell | 4 | 4 | 3 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 24 | 24 | 26 | 21 | 22 |
In the current month, UHS has received 6 Buy Ratings, 14 Hold Ratings, and 2 Sell Ratings. UHS average Analyst price target in the past 3 months is 165.83.
UHS Financial Forecast
UHS Earnings Forecast
Next quarter’s earnings estimate for UHS is CHF 4.74 with a range of CHF 4.13 to CHF 5.13. The previous quarter’s EPS was CHF 4.40. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
UHS Sales Forecast
Next quarter’s sales forecast for UHS is CHF 4.01B with a range of CHF 3.91B to CHF 4.08B. The previous quarter’s sales results were CHF 3.99B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

